Displaying 10 out of 3 results

  1. FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche enters US$1.15 billion licensing deal for Sarepta gene therapy

    Roche entered into a US$1.15 billion licensing agreement with Sarepta Therapeutics to obtain the right to launch and commercialize Sarepta's ...
  2. FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Sprin

    Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug

    Shares of Sarepta Therapeutics Inc soared 36per cent on Friday after U.S. regulators shocked Wall Street by approving the company's treatment for ...